HCP Segmentation

What is HCP segmentation?

HCP segmentation divides a target universe into groups that behave alike, so a company can decide which message, channel and frequency fits each group. It works alongside HCP targeting: targeting decides who to engage, while segmentation explains how different groups should be engaged.

A useful segment is large enough to act on, distinct enough to justify a different approach and identifiable in the data a field or digital team actually has. Segments that cannot be assigned to named clinicians remain research findings rather than operating tools.

Common segmentation approaches

Most models combine several of these dimensions:

Decile conventions are not universal. Many teams label the highest-volume group decile 10, while others use decile 1 for the top group, so check the definition before comparing lists.

• Value: deciles or tiers based on current or potential prescribing, procedure or patient volume.
• Behavior: early adopters, loyal users of a competitor, frequent switchers or low adopters of the drug class.
• Attitude: beliefs about efficacy, safety, cost or guidelines, usually measured through market research surveys.
• Practice setting: independent practice, health system employed, academic medical center or integrated delivery network.
• Access and channel: open to representative visits, restricted, or reachable mainly through digital channels.

Why HCP segmentation matters

Segmentation lets a brand treat loyal, persuadable and unlikely prescribers differently instead of spending evenly across all of them. A health system employed physician whose prescribing follows an institutional formulary may respond better to account-level engagement than to repeated representative visits.

For analysts, segments make performance measurable: growth in new-to-brand prescriptions (NBRx) within persuadable segments is a sharper signal than total volume. Segments also guide message testing, launch sequencing and medical affairs planning.

Limitations of segmentation models

Value segments built only from Medicare Part D data skew toward clinicians with older patient panels. Attitudinal segments rely on survey samples that must be projected onto the wider universe with statistical models, which adds error. Segments also age as health systems acquire practices and prescribing shifts, so models need regular refreshes.